Advancement of Nalbuphine ER Through Clinical Development in Multiple Indications New Haven, CT, August 12, 2019– Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions,today […]
Integration will benefit customers with increased inventory availability and expanded offerings in the Southeast HURST, TX August 1, 2019– Fenix Parts, Inc.and its affiliates (“Fenix Parts”), a leading recycler and reseller of original equipment manufacturer automotive products, announced […]
NEW HAVEN, Conn., Sept. 05, 2019 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions, today announced that Jennifer L. Good, President […]
We recently spoke with a client prospect who expressed frustration that press releases they paid to distribute through a wire service did not get picked up by the media. The company did not issue releases on a regular basis and […]